全肠内营养诱导儿童克罗恩病缓解的作用及机制

doi:10.16139/j.1007-9610.2018.01.018

摘要/Abstract

中图分类号:

R459.3

黄雨桦, 李幼生. 全肠内营养诱导儿童克罗恩病缓解的作用及机制[J]. 外科理论与实践, 2018, 23(01): 77-80.

[1] Turunen P, Ashorn M, Auvinen A, et al.Long-term health outcomes in pediatric inflammatory bowel disease: a population-based study[J]. Inflamm Bowel Dis,2009,15(1):56-62.
[2] Swaminath A, Feathers A, Ananthakrishnan AN, et al.Systematic review with Meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn′s disease[J]. Aliment Pharmacol Ther,2017,46(7):645-656.
[3] Lichtenstein GR, Yan S, Bala M, et al.Remission in patients with Crohn′s disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries[J]. Am J Gastroenterol,2004,99(1):91-96.
[4] Day AS, Whitten KE, Lemberg DA, et al.Exclusive enteral feeding as primary therapy for Crohn′s disease in Australian children and adolescents: a feasible and effective approach[J]. J Gastroenterol Hepatol,2006,21(10):1609-1614.
[5] Borrelli O, Cordischi L, Cirulli M, et al.Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn′s disease: a randomised controlled open-label trial[J]. Clin Gastroenterol Hepatol,2006,4(6):744-753.
[6] Whitten KE, Leach ST, Bohane TD, et al.Effect of exclusive enteral nutrition on bone turnover in children with Crohn′s disease[J]. J Gastroenterol,2010,45(4):399-405.
[7] Heuschkel RB, Menache CC, Megerian JT, et al.Enteral nutrition and corticosteroids in the treatment of acute Crohn′s disease in children[J]. J Pediatr Gastroenterol Nutr,2000,31(1):8-15.
[8] Dziechciarz P, Horvath A, Shamir R, et al.Meta-analysis: enteral nutrition in active Crohn′s disease in children[J]. Aliment Pharmacol Ther,2007,26(6):795-806.
[9] Lochs H, Dejong C, Hammarqvist F, et al.ESPEN guidelines on enteral nutrition: gastroenterology[J]. Clin Nutr,2006,25(2):260-274.
[10] Ruemmele FM, Veres G, Kolho KL, et al.Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn′s disease[J]. J Crohns Colitis,2014,8(10):1179-1207.
[11] Baert F, Moortgat L, van Assche G, et al. Mucosal hea-ling predicts sustained clinical remission in patients with early-stage Crohn′s disease[J]. Gastroenterology,2010, 138(2):463-468.
[12] Borrelli O, Cordischi L, Cirulli M, et al.Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn′s disease: A randomized controlled open-label trial[J]. Clin Gastroenterol Hepatol,2006,4(6):744-753
[13] Berni Canani R, Terrin G, Borrelli O, et al.Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn′s disease[J]. Dig Liver Dis,2006,38(6):381-387.
[14] Grover Z, Burgess C, Muir R, et al.Early mucosal hea-ling with exclusive enteral nutrition is associated with improved outcomes in newly diagnosed children with luminal Crohn′s disease[J]. J Crohns Colitis,2016,10(10):1159-1164.
[15] Luo Y, Yu J, Zhao H, et al.Short-term efficacy of exclusive enteral nutrition in pediatric Crohn′s disease: practice in China[J]. Gastroenterol Res Pract,2015:428354.
[16] Soo J, Malik BA, Turner JM, et al.Use of exclusive enteral nutrition is just as effective as corticosteroids in newly diagnosed pediatric Crohn′s disease[J]. Dig Dis Sci,2013,58(12):3584-3591.
[17] Lee D, Baldassano RN, Otley AR, et al.Comparative effectiveness of nutritional and biological therapy in North American children with active Crohn′s disease[J]. Inflamm Bowel Dis,2015,21(8):17861793.
[18] Grover Z, Lewindon P.Two-year outcomes after exclusive enteral nutrition induction are superior to corticosteroids in pediatric Crohn′s disease treated early with thiopurines[J]. Dig Dis Sci,2015,60(10):3069-3074.
[19] Lambert B, Lemberg DA, Leach ST, et al.Longer-term outcomes of nutritional management of Crohn′s disease in children[J]. Dig Dis Sci,2012,57(8):2171-2177.
[20] Hradsky O, Copova I, Zarubova K, et al.Time to relapse in children with Crohn′s disease treated with azathioprine and nutritional therapy or corticosteroids[J]. Dig Dis Sci,2016,61(7):2041-2050.
[21] Connors J, Basseri S, Grant A, et al.Exclusive enteral nutrition therapy in pediatric Crohn′s disease results in long-term avoidance of corticosteroids: results of a propensity-score matched cohort analysis[J]. J Crohns Colitis,2017,11(9):1063-1070.
[22] Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn′s disease[J]. Cochrane Database Syst Rev,2007,24(1):CD000542.
[23] Grogan JL, Casson DH, Terry A, et al.Enteral feeding therapy for newly diagnosed pediatric Crohn′s disease: A double-blind randomized controlled trial with two years follow-up[J]. Inflamm Bowel Dis,2012,18(2):246-253.
[24] Afzal NA, Davies S, Paintin M, et al.Colonic Crohn′s disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved[J]. Dig Dis Sci,2005,50(8):1471-1475.
[25] de Bie C, Kindermann A, Escher J. Use of exclusive enteral nutrition in paediatric Crohn′s disease in The Netherlands[J]. J Crohns Colitis,2013,7(4):263-270.
[26] Rubio A, Pigneur B, Garnier-Lengline H, et al.The efficacy of exclusive nutritional therapy in paediatric Crohn′s disease, comparing fractionated oral vs. continuous enteral feeding[J]. Aliment Pharmacol Ther,2011,33(12):1332-1339.
[27] Buchanan E, Gaunt WW, Cardigan T, et al.The use of exclusive enteral nutrition for induction of remission in children with Crohn′s disease demonstrates that disease phenotype does not influence clinical remission[J]. Aliment Pharmacol Ther,2009,30(5):501-507.
[28] Frivolt K, Schwerd T, Werkstetter KJ, et al.Repeated exclusive enteral nutrition in the treatment of paediatric Crohn′s disease: predictors of efficacy and outcome[J]. Aliment Pharmacol Ther,2014,39(12):1398-1407.
[29] Heuschkel R.Enteral nutrition should be used to induce remission in childhood Crohn′s disease[J]. Dig Dis,2009, 27(3):297-305.
[30] El-Matary W.Enteral nutrition as a primary therapy of Crohn′s disease: the pediatric perspective[J]. Nutr Clin Pract,2009,24(1):91-97.
[31] Wang H, Shi P, Zuo L, et al.Dietary nondigestible polysaccharides ameliorate intestinal epithelial barrier dysfunction in IL-10 knockout mice[J]. J Crohns Colitis,2016,10(9):1076-1086.
[32] Nahidi L, Corley SM, Wilkins MR, et al.The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based ana-lysis[J]. Genes Nutr,2015,10(5):479.
[33] Alhagamhmad MH, Day AS, Lemberg DA, et al.Explo-ring and enhancing the anti-inflammatory properties of polymeric formula[J]. J Parenter Enteral Nutr,2017,41(3):436-445.
[34] Gerasimidis K, Bertz M, Hanske L, et al.Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn′s disease during enteral nutrition[J]. Inflamm Bowel Dis,2014,20(5):861-871.
[35] Quince C, Ijaz UZ, Loman N, et al.Extensive modulation of the fecal metagenome in children with Crohn's disease during exclusive enteral nutrition[J]. Am J Gastroenterol,2015,110(12):1718-1729.
[36] Kaakoush NO, Day AS, Leach ST, et al.Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn′s disease[J]. Clin Transl Gastroenterol,2015,6:e71.
[37] Lewis JD, Chen EZ, Baldassano RN, et al.Inflammation, antibiotics, and dietas environmental stressors of the gut microbiome in pediatric Crohn′s disease[J]. Cell Host Microbe,2015,18(4):489-500.
[38] Schwerd T, Frivolt K, Clavel T, et al.Exclusive enteral nutrition in active pediatric Crohn disease: effects on intestinal microbiota and immune regulation[J]. J Allergy Clin Immunol,2016,138(2):592-596.

全肠内营养诱导儿童克罗恩病缓解的作用及机制

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陈聪燕, 王俊青, 陈拥军. 肠道菌群与肝癌的发病机制[J]. 外科理论与实践, 2022, 27(3): 256-260.
[2]	许飞, 尹明月, 王伟, 董治亚, 陆文丽, 余熠, 王歆琼, 王俊祺, 肖园. 性早熟女童肠道菌群和抗生素耐药性的宏基因组分析[J]. 诊断学理论与实践, 2022, 21(01): 52-61.
[3]	高铭, 李娜, 刘煜. 脑-肠轴与2型糖尿病相关性的研究进展[J]. 内科理论与实践, 2021, 16(06): 418-421.
[4]	李林, 安静静, 王俊祺, 王歆琼, 董治亚. 16S rRNA第二代测序技术分析特发性身材矮小儿童肠道菌群构成的特征及相关发病机制研究[J]. 诊断学理论与实践, 2021, 20(02): 149-154.
[5]	李惠, 冯洁, 韩立中. 高通量测序技术分析无特定病原体级实验小鼠肠道的菌群组成[J]. 诊断学理论与实践, 2020, 19(1): 55-62.
[6]	安静静, 王俊祺, 肖园, 陆文丽, 李林, 王伟, 董治亚. 16S rRNA高通量测序分析肠道菌群对小于胎龄大鼠生长追赶的影响及其可能的机制[J]. 诊断学理论与实践, 2020, 19(04): 375-380.
[7]	张雪莹, 秦环龙. 肠道菌群作为结肠直肠癌生物标志物及其干预的临床意义[J]. 外科理论与实践, 2020, 25(02): 155-158.
[8]	陈瑶瑶, 顾爱华. 氧化三甲胺与心血管疾病关系的研究进展[J]. 诊断学理论与实践, 2019, 18(2): 237-240.
[9]	陆启帆, 蒋兆彦, 王启晗, 赵刚, 胡海. 牛磺熊去氧胆酸预防高脂饮食小鼠胆囊结石的研究[J]. 外科理论与实践, 2019, 24(06): 522-529.
[10]	陈超波, 蒋兆彦. 胆汁酸代谢与非酒精性脂肪性肝病[J]. 外科理论与实践, 2019, 24(04): 371-374.
[11]	汪婷婷, 郑乃盛, 袁向亮, 沈立松. 基于16S rRNA高通量测序技术分析小鼠实验性结肠炎肠道菌群结构特征[J]. 诊断学理论与实践, 2019, 18(03): 263-270.
[12]	蒋兆彦, 胡海, 韩天权, 张圣道. 肠道菌群改变与胆固醇结石病[J]. 外科理论与实践, 2019, 24(02): 93-95.
[13]	陆伦根, 胡江峰,. 肠道菌群与胆汁酸的研究进展[J]. 内科理论与实践, 2018, 13(06): 329-333.
[14]	陈施吾, 王刚,. 帕金森病与肠道菌群关系的研究进展[J]. 内科理论与实践, 2018, 13(05): 316-319.
[15]	田锋, 王新颖,. 肠道菌群与肠黏膜固有免疫[J]. 外科理论与实践, 2016, 21(01): 79-82.